Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy

C Serratrice, S Carballo, J Serratrice… - Core evidence, 2016 - Taylor & Francis
Introduction: Gaucher disease is the first lysosomal disease to benefit from enzyme
replacement therapy, thus serving as model for numerous other lysosomal diseases …

Recombinant enzymes in the food and pharmaceutical industries

D Trono - Advances in enzyme technology, 2019 - Elsevier
The industrial demand for enzymes is constantly increasing, with the global enzyme market
dominated by the food and pharmaceutical industries. However, the use of enzymes is still …

[HTML][HTML] Hematological findings in lysosomal storage disorders: a perspective from the medical laboratory

AF Leal, WG Nieto, E Candelo, H Pachajoa… - EJIFCC, 2022 - ncbi.nlm.nih.gov
Lysosomal storage disorders (LSDs) are a group of rare and genetic diseases produced by
mutations in genes coding for proteins involved in lysosome functioning. Protein defect …

[HTML][HTML] Diagnosis and management of hematological manifestations of Gaucher disease: Insights from Saudi Arabia

T Owaidah, F Alabbas, I Alhazmi… - Journal of Applied …, 2021 - journals.lww.com
Gaucher disease (GD) is a lysosomal storage disorder that occurs due to an inherited inborn
error of metabolism. GD manifested due to the deficient activity of the glucocerebrosidase …

[HTML][HTML] Fever, pulmonary interstitial fibrosis, and hepatomegaly in a 15-year-old boy with Gaucher disease: a case report

M Yang - Journal of Medical Case Reports, 2018 - Springer
Background Gaucher disease is an autosomal recessive disorder resulting from the
accumulation of glucocerebroside in the cells of the macrophage-monocyte system caused …

Small Bowel Mucosal Involvement and Mesenteric Mass Formation in a Young Female with Type 3 Gaucher Disease. A.

AJ Emanuel, N Holman, SE Presnell… - … of Gastrointestinal & …, 2018 - search.ebscohost.com
Gaucher Disease arises due to a deficiency in the enzyme glucocerebrosidase and is the
most common lysosomal storage disease. This enzyme deficiency leads to the accumulation …

[PDF][PDF] Role of nursing care of patient with Gaucher disease, with implanted venous access port–a case study

P Więch, K Suchy, D Bazaliński… - Anest …, 2017 - akademiamedycyny.pl
Background. Gaucher disease is a genetic metabolic disorder, associated with significant
decrease in betaglucocerebrosidase activity. Because of the large number of procedures …

[HTML][HTML] Gaucher's disease: a rare case, diagnosed by fine needle aspiration cytology

RR Bharti, B Kumar - Journal of Clinical and Diagnostic Research …, 2016 - ncbi.nlm.nih.gov
Abstract Fine Needle Aspiration (FNA) is a simple, inexpensive and innocuous diagnostic
tool. It is increasingly accepted in daily medical practice. We report a case of Gaucher's …

The Role of Liver Function Tests in Monitoring the effect of Enzyme Replacement Therapy in Children with Gaucher Disease

HA Abdulamir, AAA Aldafaay… - Research Journal of …, 2022 - indianjournals.com
Background Gaucher disease (GD) is an autosomal recessive hereditary disease. The
etiology, pathophysiology, diagnosis, and prognosis of GD in children might all be affected …

[PDF][PDF] INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACEUTICAL SCIENCES

YSJ Alrubaye, MBM Al-Juboori, HA Abdulamir - 2020 - pdfs.semanticscholar.org
To assess the role of γ-Glutamyltransferase (GGT) and alkaline phosphatase (ALP) in the
diagnosis of Gaucher disease (GD) and monitoring the response of liver and bone to the …